Sona Nanotech advances toward first-in-human gold nanorod trial -...
Sona Nanotech Inc (CSE:SONA, OTCQB:SNANF) chief medical officer Dr Carman Giacomantonio joined Proactive to discuss a critical development in the company’s gold nanorod cancer therapy. Dr Giacomantonio talked about the company’s progress as it moves toward …